Oxford Science Enterprises Raises $300M To Search For New Cures – Crunchbase News
BusinessFast,
Oxford Science Enterprises announced on Monday it raised nearly $300 million in fresh funding, bringing its total raised to $1…
Letters to the Editor: 'Value-based drug pricing' is doublespeak for a deadly system
Yahoo! News,
To the editor: In an op-ed article, researchers from Tufts University assert that "to strike the right balance, policymakers…
News story from Los Angeles Times on Friday 15 July 2022
Los Angeles Times,
News story from Stat News on Tuesday 18 January 2022
Stat News,
News story from Stat News on Monday 03 January 2022
Stat News,
Big lie behind who gets to make COVID vaccines won't protect us
Newsbreak,
Global health experts’ predictions are being realized. In the midst of tragically unequal vaccination access, a new variant of…
Big lie behind who gets to make COVID vaccines won't protect us
Yahoo!,
Global health experts’ predictions are being realized. In the midst of tragically unequal vaccination access, a new variant of…
Big lie behind who gets to make COVID vaccines won't protect us
USA Today,
Global health experts’ predictions are being realized. In the midst of tragically unequal vaccination access, a new variant of…
Steve Bannon faces last chance to testify on Capitol attack or risk contempt charges – live
PressNewsAgency,
11.23am EDT 11:23 Jake Sherman (@JakeSherman) NEW — in a letter to senate democrats, @SenSchumer announces he’ll file cloture…
Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop
Newsbreak,
Last week, we learned that Merck is planning to charge Americans 40 times its cost for a Covid drug whose development was…
Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop
Yahoo! News,
Last week, we learned that Merck is planning to charge Americans 40 times its cost for a Covid drug whose development was…
Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop | David Sirota
The Guardian,
Last week, we learned that Merck is planning to charge Americans 40 times its cost for a Covid drug whose development was…
It's Time to Build American Health Care Back Better
Common Dreams,
I am writing this from a bus somewhere in West Virginia. It’s lightly raining, and the air is chill to the touch.
Will Movement for People's Vaccine Open Doors to Larger Revolt Against Big Pharma?
Common Dreams,
When the Biden Administration announced it would no longer oppose suspension of Trade Related Aspects of Intellectual Property…
Column: Biden's plan to waive vaccine patents is good news, but not enough to beat the pandemic
Yahoo! Finance USA,
The pharmaceutical industry, which thought it had entered the can-do-no-wrong stage of public esteem thanks to its development…
News story from Los Angeles Times on Thursday 06 May 2021
Los Angeles Times,
Column: Biden’s plan to waive vaccine patents is good news, but not enough to beat the pandemic
Newsbreak,
The pharmaceutical industry, which thought it had entered the can-do-no-wrong stage of public esteem thanks to its development…
Public Health Must Be the Highest Law
The Wire,
A healthcare worker gives a dose of Covishield to a woman inside a school converted into a temporary vaccination centre, in New…
It’s Time For Congress To Go All In On Drug Pricing Reform
Health Affairs,
The partisan stars appear to be aligned in Washington on passing federal drug pricing reform, but not without its share of…
March-In Rights And Compulsory Licensing—Safety Nets For Access To A COVID-19 Vaccine
Health Affairs,
In 1955, journalist Edward R. Murrow asked Jonas Salk: Who owns the patent to the polio vaccine? He responded famously, “Well…
Lower Drug Costs Now
Health Affairs,
As Americans, we like to think of ourselves as number one in everything, but in some cases — health care costs prime among them …
So You Think Private Sector is More Innovative Than Public Sector?
Medium US,
It’s the taxpayer money that creates an environment for private enterprises to flourish Mehboob Khan 3 hours ago · 7 min read…
Opinion | Taxpayers Fund Research and Drug Companies Make a Fortune
New York Times,
Opinion|Taxpayers Fund Research and Drug Companies Make a Fortune The pharmaceutical industry doesn’t want things to change…
COVID-19 As a Catalyst for Changing Orphan-Drug Regulations
BioProcess International,
A long-awaited (and for months withheld) evaluation of the European Union’s Orphan Drug Regulation (ODR) finally reached the…
We Already Paid for These Vaccines Once
The Nation,
Amid the continued pandemic-induced horror, we find ourselves getting emotional over our fellow health care workers’ social…
Column: Pfizer, Moderna expect billions in profits from COVID vaccines. That's a scandal
Yahoo! Finance USA,
The pharmaceutical industry, which has ranked near the bottom in its public reputation for what seems like decades, is…
News story from Los Angeles Times on Monday 04 January 2021
Los Angeles Times,
Private firms keep stranglehold on tax-funded COVID vaccines
The Keene Sentinel ,
The biotech company Moderna injected a new dose of optimism into the fight against COVID-19 on Monday by announcing that its…
Michael Hiltzik: Private firms keep stranglehold on COVID vaccines, though you paid for the research
Killeen Daily Herald,
The biotech company Moderna injected a new dose of optimism into the fight against COVID-19 on Monday by announcing that its…
Michael Hiltzik: Private firms keep stranglehold on COVID vaccines, though you paid for the research
Fox News 26,
The biotech company Moderna injected a new dose of optimism into the fight against COVID-19 on Monday by announcing that its…
Michael Hiltzik: Private firms keep stranglehold on COVID vaccines, though you paid for the research
The Bakersfield Californian,
The biotech company Moderna injected a new dose of optimism into the fight against COVID-19 on Monday by announcing that its…
Who owns the COVID-19 vaccines? To a great extent, you do — but you may not see the profits
Yahoo! Finance USA,
The biotech company Moderna injected a new dose of optimism into the fight against COVID-19 on Monday by announcing that its…
News story from Los Angeles Times on Monday 16 November 2020
Los Angeles Times,
Medication affordability: A new vital sign to screen for in primary care
Healio.com,
6 min read Source/Disclosures Source: Kuwahara RK, Marhatta A. “Prescription Drug Affordability as a New Vital Sign: Strategies…
Gilead is protecting its drug patent instead of protecting COVID-19 patients
Morning Star,
By Rex Nutting By refusing to test a promising drug, Gilead Sciences is accused of putting profit ahead of the public health…
Is Trump bluffing on prescription drug price rules?
WND,
[ Editor's note: This story originally was published by Real Clear Politics. ] By Greg Orman Real Clear Politics This week…
A pesquisa na indústria farmacêutica depende do governo?
Money Times,
Pelas regras da agência de vigilância sanitária dos EUA (a Food and Drug Administration – FDA), um tratamento contra o câncer…
Remdesivir – a Drug in Search of a Disease
The Wire,
A vial of pure remdesivir. Photo: Gilead Sciences Inc/Handout via Reuters. ‘Marketism’ is the notion that markets are not a…
Yes, the government can control the cost of a coronavirus vaccine | Opinion
Newsweek,
When I was diagnosed at age 32 with ALS, a debilitating disease that would give me a life expectancy of three to four years, my…
March-In Rights And Compulsory Licensing—Safety Nets For Access To A COVID-19 Vaccine
Health Affairs,
In 1955, journalist Edward R. Murrow asked Jonas Salk: Who owns the patent to the polio vaccine? He responded famously, “Well…
How open-source medicine could prepare us for the next pandemic
Fast Company,
The old drug discovery system was built to benefit shareholders, not patients. But a new, Linux-like platform could transform…
If You Think Coronavirus Profiteering Is Bad, Wait Till the Climate Heats Up
Common Dreams,
COVID-19 is testing the U.S. public health system. And, unfortunately, things don’t look so good — especially if you’re one of…
Trump trying to buy a coronavirus vaccine shows why big pharma needs to change
Yahoo! News,
Pandemics don’t destroy societies, but they do expose their weaknesses. As the historian of medicine Frank Snowden recently…
Trump trying to buy a coronavirus vaccine shows why big pharma needs to change | Diarmaid McDonald
The Guardian,
Pandemics don’t destroy societies, but they do expose their weaknesses. As the historian of medicine Frank Snowden recently…
How much will drug price controls harm innovation? It depends
Medcity News,
For all their differences, particularly in election season, Democrats and Republicans seem to agree on one thing: Drug prices…
Trump’s proposed NIH cuts show disregard for importance of basic research
Medcity News,
One of the most memorable moments during the 2008 presidential election was when vice presidential candidate Sarah Palin…
Comment une piqûre pour soigner des bébés peut coûter 2 millions de francs
Radio Television Suisse,
Une injection synonyme d'espoirs. Le Zolgensma, un nouveau traitement de Novartis, pourrait améliorer le quotidien des enfants…
The excruciatingly obvious reason Americans keep paying sky-high drug prices
NBC News,
Bottom line: The status quo is unhealthy for anyone except pharmaceutical company executives.
Opinion: Health Reform in America—Where Are the Scientists?
The Scientist Magazine,
O ver the past decade, Americans have debated the best way to fix our broken healthcare system, one that allows 35,000…
The State Helps Float Risky Medical Research. Why Don't Patents Benefit It?
The Wire,
I have often asked my students, “To what extent does government funding contribute to research, leading to the development of…
Fact-check: Casten partly right about federal contribution to new drugs
Chicago Sun-Times,
Speaking in favor of a plan to lower prescription drug costs and increase funding for public research, misstated the timeframe…
News story from Stat News on Monday 23 December 2019
Stat News,
"From 2000 to 2016, every major drug that was introduced came out of" National Institutes of Health funding.
Politifact,
The day before the U.S. House of Representatives passed a bill to lower prescription drug prices, Illinois Democratic Rep.
High prescription costs are just one way the Big Pharma drug companies rip us off
Yahoo! News,
Last week's House vote torein in skyrocketing prescription drug priceswas overdue.
Drug companies rip us off on prices and much more
The Arizona Republic,
Published 3:00 a.m. MT Dec. 16, 2019 The newly passed House bill allowing Medicare negotiations on drug prices is a first step…
Drug companies rip us off on prices and much more
The Indianapolis Star,
Published 5:00 a.m. ET Dec. 16, 2019 The newly passed House bill allowing Medicare negotiations on drug prices is a first step…
Opinion Drug companies rip us off on prices and much more
Kitsap Sun,
The newly passed House bill allowing Medicare negotiations on drug prices is a first step toward taming Big Pharma and broader…
Drug companies rip us off on prices and much more
Statesman Journal,
Published 2:00 a.m. PT Dec. 16, 2019 The newly passed House bill allowing Medicare negotiations on drug prices is a first step…
Drug companies rip us off on prices and much more
Detroit Free Press,
Published 5:00 a.m. ET Dec. 16, 2019 The newly passed House bill allowing Medicare negotiations on drug prices is a first step…
Drug companies rip us off on prices and much more
The Greenville News,
Published 5:00 a.m. ET Dec. 16, 2019 The newly passed House bill allowing Medicare negotiations on drug prices is a first step…
Defeating the HIV epidemic is more about politics than science
Yahoo! News,
Across the United States, a renewed grassroots movement is fighting to fundamentally change the rules of healthcare.
Defeating the HIV epidemic is more about politics than science
The Guardian,
Across the United States, a renewed grassroots movement is fighting to fundamentally change the rules of healthcare.
MIL-OSI USA: DeFazio Introduces Bill to Require Affordable Pricing on Taxpayer-Funded Prescription Drugs
Foreign Affairs New Zealand,
Source: United States House of Representatives – Congressman Peter DeFazio (4th District of OREGON) WASHINGTON, DC–Rep.
You might be surprised at how far Americans are willing to go to overthrow the power of Big Pharma
Alternet,
As the 2020 election looms, “Morning Joe” pundits love to talk about “electability.” The out-of-touch television personalities…
You Might Be Surprised at How Far Americans Are Willing to Go to Overthrow the Power of Big Pharma
Common Dreams,
As the 2020 election looms, "Morning Joe" pundits love to talk about "electability." The out-of-touch television personalities…
News story from Stat News on Tuesday 10 September 2019
Stat News,
Wednesday July 31, 2019 Bipartisan legislation would cap prices for drugs...
Washington Examiner,
S enators Chris Van Hollen of Maryland and Rick Scott of Florida unveiled bipartisan legislation to lower the costs of drugs…
The new bipartisan Senate bill aimed at making Big Pharma lower drug prices, explained
MSN,
When it comes to government funding for drug research, an interesting paradox currently exists.
The new bipartisan Senate bill aimed at making Big Pharma lower drug prices, explained
Vox.com,
When it comes to government funding for drug research, an interesting paradox currently exists.
Recruiting for Oncology
Medical Health News,
In the last decade, innovations in cell and gene-based therapies have changed the Oncology recruitment market.
Progressive Democrats Have a Plan to Drastically Lower Drug Prices for Medicare Beneficiaries
Forbes,
Medicare is prohibited by law from doing what every other health insurance company does.
House Ways
Insurance News Net,
Targeted News Service WASHINGTON, March 7 -- The House Ways and Means subcommittee on Health issued the following testimony by…
Five Takeaways from the Senate Finance Committee’s Hearing on Drug Pricing
The National Law Review,
, the Senate Finance Committee heard testimony from top executives representing seven high-profile drug manufacturers.
Opinion | How High Drug Prices Inflate C.E.O.s’ Pay
New York Times,
Opinion|How High Drug Prices Inflate C.E.O.s’ Pay Pharmaceutical companies say their profits fund research and innovation in…
Bernie Sanders And Ro Khanna Have A New Plan To Tackle Prescription Drug Rip-Offs
Huffington Post,
The problem with prescription drugs is simple: The U.S. government bestows long-term monopolies on pharmaceutical companies…
Bernie Sanders And Ro Khanna Have A New Plan To Tackle Prescription Drug Rip-Offs
Yahoo! News,
The problem with prescription drugs is simple: The U.S. government bestows long-term monopolies on pharmaceutical companies…
A Nobel Prize-Winning Cancer Therapy Will Be Unaffordable for Most Americans. Public Pharmaceuticals Can Help Change That.
Common Dreams,
Last week, researchers James Allison and Tasuku Honjo were awarded this year's Nobel Prize in medicine for their work on cancer…
Nobel Prize is a reminder of the outrageous cost of curing cancer
MSN,
For the first time ever, we’re living in a moment when many of our most promising medical advances are far out of reach for the…
The 2018 Nobel Prize is a reminder of the outrageous cost of curing cancer
Vox.com,
For the first time ever, we’re living in a moment when many of our most promising medical advances are far out of reach for the…
Democrats have a Medicare negotiation plan that terrifies Big Pharma
The Hill,
Our Declaration of Independence proclaims that all of us have been “endowed with certain unalienable Rights” that include “Life…
News story from Stat News on Friday 20 July 2018
Stat News,
News story from Stat News on Wednesday 06 June 2018
Stat News,
‘Paying Twice’: A Push for Affordable Prices for Taxpayer-Funded Drugs
New York Times,
WASHINGTON — On Aug. 30, the Food and Drug Administration approved a radical new cancer treatment that harnesses a patient’s…
‘Paying Twice’: A Push for Affordable Prices for Taxpayer-Funded Drugs
New York Times,
WASHINGTON — On Aug. 30, the Food and Drug Administration approved a radical new cancer treatment that harnesses a patient’s…
‘Paying twice’: A push for affordable prices for taxpayer-funded drugs
The Santa Fe New Mexican,
WASHINGTON — On Aug. 30, the Food and Drug Administration approved a radical new cancer treatment that harnesses a patient’s…
Opinion | Trump’s Drug Plan: Not an Effective Rx
New York Times,
Letters May 18, 2018 To the Editor: Re “Drug Plan Drops Populist Designs, Not the Rhetoric” (front page, May 12): President…
No, raising drug prices in Canada will not help the U.S.
MedicalXpress,
Donald Trump's solution to soaring American drug prices is to have other countries, such as Canada, raise their prices.
No, raising drug prices in Canada will not help the U.S.
The Conversation,
Donald Trump’s solution to soaring American drug prices is to have other countries, such as Canada, raise their prices.
NIH Funding Needs to Keep Rising, Senators Say
MedPage Today,
WASHINGTON -- Federal funding for the National Institutes of Health (NIH) needs to continue going up, Sen.
Taxpayers—Not Big Pharma—Have Funded the Research Behind Every New Drug Since 2010
Alternet,
A sweeping new study challenges our understanding of medical breakthroughs. Something odd happened when the Trump…
How many new drugs rely on government-funded science? All of them
CBC,
This is an excerpt from Second Opinion, a weekly roundup of eclectic and under-the-radar health and medical science news…
NIH research contributed to all new FDA-approved drugs from 2010 to 2016, report says | February 19, 2018 Issue - Vol. 96 Issue 8
C&EN,
Volume 96 Issue 8 | p. 17 | Concentrates Issue Date: February 19, 2018 NIH-funded research was associated with all 210 new…
Your Tax Dollars Fund Research on Hundreds of New Meds
Medicinenet,
Latest Prevention
Study: $100B over six years led to 210 new FDA-approved medications
UPI.com,
THURSDAY, Feb. 15, 2018 -- The U.S. National Institutes of Health spent more than $100 billion on research that led to 210 new…
Your Tax Dollars Fund Research on Hundreds of New Meds
Doctors Lounge,
Category: Family Medicine | Pharmacy | Research | News THURSDAY, Feb. 15, 2018 (HealthDay News) -- The U.S.
Your Tax Dollars Fund Research on Lots of New Meds
WebMD News,
By Robert Preidt HealthDay Reporter THURSDAY, Feb. 15, 2018 (HealthDay News) -- The U.S.
Your Tax Dollars Fund Research on Hundreds of New Meds
Philly.com,
THURSDAY, Feb. 15, 2018 (HealthDay News) -- The U.S. National Institutes of Health spent more than $100 billion on research…
Your Tax Dollars Fund Research on Hundreds of New Meds
USNews.com,
By Robert Preidt, HealthDay Reporter THURSDAY, Feb. 15, 2018 (HealthDay News) -- The U.S.
Your Tax Dollars Fund Research on Hundreds of New Meds
Drugs.com,
THURSDAY, Feb. 15, 2018 -- The U.S. National Institutes of Health spent more than $100 billion on research that led to 210 new…
Your Tax Dollars Fund Research on Hundreds of New Meds
Rocket News,
THURSDAY, Feb. 15, 2018 (HealthDay News) — The U.S. National Institutes of Health spent more than $100 billion on research that…